MedTrace Logo

Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors

NCT03120390 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-12-17

No results posted yet for this study

Summary

This randomized phase II trial studies how well physical activity works in reducing metabolic dysregulation in obese Latina breast cancer survivors. Physical activity may improve fitness and lessen metabolic disease (such as coronary artery disease, stroke, and type 2 diabetes) risk factors in patients who have breast cancer.

Conditions

  • Cancer Survivor
  • Central Obesity
  • No Evidence of Disease

Interventions

OTHER

Best Practice

Undergo usual care

BEHAVIORAL

Exercise Intervention

Undergo AE

BEHAVIORAL

Exercise Intervention

Undergo RE

OTHER

Laboratory Biomarker Analysis

Correlative studies

DEVICE

Monitoring Device

Receive Polar heart rate monitor

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Christina Dieli-Conwright, Ph.D. · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-08
Primary Completion
2019-07-31
Completion
2019-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03120390 on ClinicalTrials.gov